View Older Stories View More Recent Stories
-
Philip Morris (PM) PT Raised to $209 at BofA Securities
-
Philip Morris names Massimo Andolina as new CFO starting August 2026
-
Tobacco stocks soar on FDA guidance
-
Goldman on Philip Morris (PM): 'remains one of our top stock ideas'
-
Jefferies sees FDA's fruit-flavoured eVape approval as positive for BAT
-
Trump pressures FDA chief on flavored vape approvals - WSJ
-
Barclays reports US tobacco data shows cigarette volume decline
-
Stifel on Philip Morris (PM) Amid 3.55% Premarket Gain: 'We expect shares to trade higher today'
-
Philip Morris International (PM) Tops Q1 EPS by 13c, Beats on Revenue; Offers Guidance
-
Philip Morris International (PM) call put ratio 1.2 calls to 1 put into quarter results
-
FDA renews Philip Morris IQOS modified risk tobacco authorization
-
Philip Morris (PM) PT Lowered to $168 at UBS Ahead of Q1 Results
-
Philip Morris International partners with Ferrari Hypersail project
-
Philip Morris (PM) PT Lowered to $195 at Stifel on Lowered Q1 EPS Estimate
-
Goldman cuts US consumer spending growth forecast on oil price surge
-
FDA applications for nicotine pouches like Zyn, Velo delayed despite fast-track scheme amid concerns over risks to non-users, kids - Reuters
-
BofA on Tobacco: 'Legal US vapor $ sales -16% YoY for the 4- wks ended March 21'
-
Stifel on Altria (MO): 'Solid Combustibles Outlook'
-
Philip Morris US to open Tampa center, create 180 jobs
-
Philip Morris International (PM) Declares $1.47 Quarterly Dividend; 3.3% Yield
-
Philip Morris (PM) PT Raised to $181.50 at UBS: Q4 Ahead of Consensus
-
Bernstein on Philip Morris (PM): 'We fear a small negative response this morning'
-
Philip Morris (PM) PT Raised to $200 at Stifel After Strong Q4 Volumes, Margin Expansion
-
Philip Morris International (PM) files for debt offering
-
Philip Morris International (PM) Reports In-line EPS, Beats on Revenue; Offers FY26 EPS Guidance
-
Philip Morris International (PM) fourth quarter earnings preview
-
Philip Morris seeks FDA approval for reduced-risk claim on ZYN pouches
-
Jefferies Downgrades Philip Morris (PM) to Hold
-
Philip Morris (PM) Reiterated at Neutral by UBS: Might Miss 2026 Mid-term Targets
-
Increasing unusual option volume: PM MDT DVA ZSL FANG LW OMER NOW CAR RCL
-
Philip Morris International (PM) Declares $1.47 Quarterly Dividend; 3.9% Yield
-
Philip Morris International secures $2 billion credit facility
-
Bernstein's U.S. Consumer Strategy - 'Should We Prepare for a Positive Sector Rotation?'
-
Philip Morris expands Ferrari partnership to feature ZYN branding
-
Philip Morris reaffirms 2025 earnings forecast of $7.39-$7.49 per share
-
Philip Morris restructures into U.S. and international units
-
British American Tobacco Postpones Plan To Launch Unlicensed Vape In US, Reynolds Spokesperson Says - Reuters
-
Stifel Reiterates Philip Morris (PM) at Buy, Says PMI Topline, EPS Growth Profile Favourable to Peers
-
Goldman Sachs Reiterates Buy Rating on Philip Morris (PM)
-
Philip Morris (PM) PT Lowered to $175 at Morgan Stanley
-
Philip Morris International (PM) call put ratio 1.1 calls to 1 put as share price down 4.4%
-
Stifel on Philip Morris (PM): 'We view the pullback in the shares as an attractive buying point'
-
Philip Morris International (PM) Tops Q3 EPS by 15c, Beats on Revenue
-
Philip Morris earnings preview Q3: strong print expected amid Zyn momentum
-
Philip Morris International seeks FDA panel support for IQOS renewal
-
Philip Morris invests $37 million in Wilson NC manufacturing facility
-
Philip Morris International (PM) Raises Quarterly Dividend 8.9% to $1.47; 3.6% Yield
-
Philip Morris (PM) PT Lowered to $166 at UBS
-
Citi Adjust Catalyst Call List
-
Philip Morris reaffirms 2025 earnings guidance at investor conference
